Skip to main content
. 2020 Nov 30;12(12):3574. doi: 10.3390/cancers12123574

Figure 4.

Figure 4

Metabolites analysis. Box plot of the serum levels of the significantly different metabolites for the comparison between responders and non-responders in (A) nivolumab-treated patients; (B) pembrolizumab-treated patients.